(HealthDay News) — Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Relapsing Remitting Multiple Sclerosis
This study of an investigational drug taken every four weeks is for people who have relapsing remitting multiple sclerosis.
The research site is in Sunrise, Fla.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/multiple_sclerosis.aspx.
—–
Tinnitus (Ringing of the Ears)
This 29-week study will evaluatie an investigational drug in people with tinnitus. Candidates must be at aged 18 to 75 and have persistent tinnitus in one or both ears.
The research site is in Gilbert, Ariz.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/tinnitus.aspx.
—–
Gout
Participants in this study of gout will receive study-related medication, doctor visits, possible compensation and transportation.
The research site is in Costa Mesa, Calif.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/gout.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.